Back to search

Article

Longitudinal Proteomic Profiling Defines Robust Molecular Subtypes Underlying the Heterogeneity of Parkinson’s Disease

2025-12-01

Abstract excerpt

<h4>ABSTRACT</h4> Heterogeneity of Parkinson’s disease (PD) pathology is a barrier to developing therapeutics and understanding progression and prognosis. High throughput proteomic measures can be used to better interpret PD pathophysiology and generate clusters to define disease subtypes. Identification of subtypes related to clinical phenotypes will help researchers understand PD progression. We analyzed longit...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5fa1acfc-48be-566c-b81c-761f5fa49609
DOI
10.1101/2025.11.27.691036
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Longitudinal Proteomic Profiling Defines Robust Molecular Subtypes Underlying the Heterogeneity of Parkinson’s DiseaseDOI 10.1101/2025.11.27.691036
Identification of Parkinson’s disease PACE subtypes and repurposing treatments through integrative analyses of multimodal dataSemantic proximity
Proteogenomic network analysis reveals dysregulated mechanisms and potential mediators in Parkinson’s diseaseSemantic proximity
Orthogonal validation of PD Biomarkers: Multi-platform proteomics profiling of CSF, Plasma, and Urine confirms DDC as a consistent candidateSemantic proximity
Constructing Parkinson's disease progression- endotype molecular networks for drug repurposing: multi-omics evidence aggregation and large-scale real-world data validationSemantic proximity
Identification of Parkinson PACE subtypes and repurposing treatments through integrative analyses of multimodal clinical progression, neuroimaging, genetic, and transcriptomic dataSemantic proximity
Mapping Parkinson’s Disease Progression through Deep Plasma Proteomics and Functional GenomicsSemantic proximity
A Hybrid Machine Learning And Network Analysis Approach Reveals Two Parkinson's Disease Subtypes From 115 RNA-Seq Post-mortem Brain SamplesSemantic proximity
An Integrative Network Approach for Longitudinal Stratification in Parkinson’s DiseaseSemantic proximity
Identification of Conserved Proteomic Networks in Neurodegenerative Dementia.Semantic proximity
Identification of conserved proteomic networks in neurodegenerative dementiaSemantic proximity
Plasma Proteomics for Parkinson’s Disease: Diagnostic Classification, Severity Association, and Therapeutic HypothesesSemantic proximity
The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and agingSemantic proximity
Select a neighboring publication to make it the new centre.